[MSF a publié une étude en anglais sur le problème des médicaments de
qualité sub-standard dans les pays à ressources limitées. Elle est
disponible à cette adresse
http://www.msf.org.za/docs/ScientificDocs/TMIH2008_Vol13_substandards.pdf
Ci-dessous le résumé en anglais... une traduction en français serait appréciée... CB)
Tropical Medicine and International Health
doi:10.1111/j.1365-3156.2008.02106.x
volume 13 no 8 pp 10621072 august 2008
Substandard medicines in resource-poor settings: a problem
that can no longer be ignored
J.-M. Caudron1,2, N. Ford1, M. Henkens1, C. Mace´1, R. Kiddle-Monroe1 and J.
Pinel1,2
1 Medecins Sans Frontieres, Geneva, Switzerland
2 AEDES Foundation, Brussels, Belgium
Summary
The circulation of substandard medicines in the developing world is a
serious clinical and public health concern. Problems include under or over
concentration of ingredients, contamination, poor quality ingredients, poor
stability and inadequate packaging. There are multiple causes. Drugs
manufactured for export are not regulated to the same standard as those for
domestic use, while regulatory agencies in the less-developed world are
poorly equipped to assess and address the problem. A number of recent
initiatives have been established to address the problem, most notably the
WHO pre-qualification programme. However, much more action is required.
Donors should encourage their partners to include more explicit quality
requirements in their tender mechanisms, while purchasers should insist that
producers and distributors supply drugs that comply with international
quality standards. Governments in rich countries should not tolerate the
export of substandard pharmaceutical products to poor countries, while
developing country governments should improve their ability to detect
substandard medicines.